BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22488219)

  • 21. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
    Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
    Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular identification of the HLA-DRB1-DQB1 for diagnosis and follow-up of acute leukemias.
    Fernandes TA; Fukai R; Souza CA; Lorand-Metze I; Magna LA; Kraemer MH
    Blood Cells Mol Dis; 2010; 44(2):69-73. PubMed ID: 20051322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukemia specific loss of heterozygosity of MHC in a CLL patient: disease state impacts timing of confirmatory typing.
    Coppage M; Iqbal A; Ahmad A; Becker MW
    Hum Immunol; 2013 Jan; 74(1):41-4. PubMed ID: 23085343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancer.
    Tuna M; Smid M; Martens JW; Foekens JA
    Breast Cancer Res Treat; 2012 Feb; 132(1):189-96. PubMed ID: 21604015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.
    Flotho C; Steinemann D; Mullighan CG; Neale G; Mayer K; Kratz CP; Schlegelberger B; Downing JR; Niemeyer CM
    Oncogene; 2007 Aug; 26(39):5816-21. PubMed ID: 17353900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-G expression is irrelevant to prognosis in patients with acute myeloid leukemia.
    Guo QY; Chen BG; Ruan YY; Lin A; Yan WH
    Leuk Res; 2011 Oct; 35(10):1350-4. PubMed ID: 21696824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of heterozygosity leading to incorrect HLA typing for platelet-transfusion refractory patient.
    Horwath M; Tvrdik T; Saxe D; Deeb KK; Roback JD; Gebel HM; Bray RA; Sullivan HC
    Transfusion; 2023 Jan; 63(1):263-268. PubMed ID: 36426572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different mechanisms causing loss of mismatched human leukocyte antigens in relapsing t(6;11)(q27;q23) acute myeloid leukemia after haploidentical transplantation.
    Tamaki H; Fujioka T; Ikegame K; Yoshihara S; Kaida K; Taniguchi K; Kato R; Tokugawa T; Nakata J; Inoue T; Yano A; Eguchi R; Okada M; Maruya E; Saji H; Ogawa H
    Eur J Haematol; 2012 Dec; 89(6):497-500. PubMed ID: 23033942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two cases of acute lymphoid leukemia patients with loss of heterozygosity in HLA region before transplantation.
    Huang W; Xue S; Zhang Y; Liu F; Wang J
    HLA; 2021 Sep; 98(3):207-212. PubMed ID: 34288574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse.
    Wang ES; Sait SN; Gold D; Mashtare T; Starostik P; Ford LA; Wetzler M; Nowak NJ; Deeb G
    Cancer Genet Cytogenet; 2010 Oct; 202(2):101-7. PubMed ID: 20875872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute myeloid leukemia from diagnosis to bone marrow transplantation: experience from a single centre.
    Gamberi B; Bandini G; Visani G; Rosti G; Cenacchi A; Motta MR; Fruet F; Calori E; Rizzi S; Tosi P
    Bone Marrow Transplant; 1994 Jul; 14(1):69-72. PubMed ID: 7951122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor selection process for allogeneic hematopoietic stem cell transplantation at the university hospital of Düsseldorf (1997-1998).
    Enczmann J; Rinker M; Kiesel U; Kuhröber A; Kögler G; Nürnberger W; Göbel U; Wernet P
    Klin Padiatr; 1999; 211(4):218-23. PubMed ID: 10472554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A
    Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High and intermediate resolution DNA typing systems for class I HLA-A, B, C genes by hybridization with sequence-specific oligonucleotide probes (SSOP).
    Cao K; Chopek M; Fernández-Viña MA
    Rev Immunogenet; 1999; 1(2):177-208. PubMed ID: 11253946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia.
    Herr AL; Labopin M; Blaise D; Milpied N; Potter M; Michallet M; Heit W; Ferrara F; Esteve J; Arcese W; Ehninger G; Rowe JM; Kobbe G; Rosselet A; Bunjes D; Rio B; Brune M; Nagler A; Gorin NC; Frassoni F; Rocha V;
    Leukemia; 2007 Jan; 21(1):129-35. PubMed ID: 17128198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there a role for autologous stem cell transplantation for patients with acute myelogenous leukemia? A retrospective analysis.
    Novitzky N; Thomas V; du Toit C; McDonald A
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):875-84. PubMed ID: 20870030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinicopathological features in HLA-DR-negative acute myeloid leukemia].
    Muroi K; Yoshida M; Suzuki T; Amemiya Y; Hatake K; Miura Y
    Rinsho Ketsueki; 1997 Aug; 38(8):631-7. PubMed ID: 9311267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haematopoietic transplant potential of unrelated and related cord blood: the first six years of the EUROCORD/NETCORD Bank Germany.
    Kögler G; Somville T; Göbel U; Hakenberg P; Knipper A; Fischer J; Adams O; Krempe C; McKenzie C; Rüttgers H; Meier W; Bellmann O; Streng H; Ring A; Rosseck U; Rocha V; Wernet P
    Klin Padiatr; 1999; 211(4):224-32. PubMed ID: 10472555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletions of chromosome arms 7p and 7q in adult acute myeloid leukemia: a marker chromosome confirmed by array comparative genomic hybridization.
    Woo KS; Kim KE; Kim KH; Kim SH; Park JI; Shaffer LG; Han JY
    Cancer Genet Cytogenet; 2009 Oct; 194(2):71-4. PubMed ID: 19781438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.